arrow
D

Daniel J. Weisdorf

university of minnesota
H指数:126
被引数:7.5万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Decentralized CAR-T production: clinical, economic, and regulatory perspectives. Worldwide Network for Blood & Marrow Transplantation (WBMT) special article

去中心化CAR-T生产:临床、经济和监管视角。世界血液与骨髓移植网络(WBMT)专题文章

2026-09-240
PRE
Health status impairments in tyrosine kinase inhibitor-treated chronic myeloid leukemia patients versus blood or marrow transplant survivors and non-cancer controls

酪氨酸激酶抑制剂治疗的慢性髓性白血病患者的健康状况受损情况与血液或骨髓移植幸存者及非癌症对照者的比较

Leukemia
IF13.4
2026-08-210
OAAI
Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy

同种异基因造血细胞与器官移植的相似性与差异,以及我们如何相互借鉴以指导全球健康策略

2025-10-010
OAAI
Correction: Non-cryopreserved autologous peripheral blood stem cell transplantation for multiple myeloma and lymphoma in countries with limited resources: practice considerations from the Worldwide Network for Blood and Marrow Transplantation

更正:在资源有限国家中,使用非冷冻保存的自体外周血干细胞移植治疗多发性骨髓瘤和淋巴瘤:来自世界骨髓移植联盟的实践考量

2025-06-300
PRE
Setting up a Chimeric Antigen Receptor T Cell Therapy Program: A Framework for Delivery from the Worldwide Network for Blood & Marrow Transplantation

建立嵌合抗原受体T细胞疗法项目:世界造血与骨髓移植网络交付框架

2025-05-230
PRE
Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Lymphoid Malignancies- a BMT Survivor Study (BMTSS)

淋巴恶性肿瘤造血干细胞移植(BMT)幸存者高风险健康行为的预测因素——造血干细胞移植幸存者研究(BMTSS)

BLOOD
IF23.1
2024-11-050
PRE
Predictors of Risky Health Behaviors Among Blood or Marrow Transplant (BMT) Survivors of Myeloid Malignancies- a BMT Survivor Study (BMTSS)

髓系恶性肿瘤的血或骨髓移植(BMT)幸存者中危险健康行为的影响因素——一项BMT幸存者研究(BMTSS)

BLOOD
IF23.1
2024-11-050
PRE
Amphiregulin, ST2, and REG3 α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD
2024-06-140
OAAI